Lung cancer needs to be prioritized as one of America’s top-5 public health problems. Learn how the VA understands this and is addressing it through a national initiative known as LPOP: https://t.co/swCMZ4060h

What does this even mean? Where’s the URGENCY? 🫁

Drive your trading strategy forward with CME Group.

These images taken at a local CVS will predictably TRIGGER a lot of radiation oncologists who often argue with urologists about surgery for prostrate cancer.

He gave her a bouquet of flowers? That’s next level! @NehaVapiwala

Congratulations to President @JoeBiden for finishing RT under the care of @ASTRO_org President @NehaVapiwala @PennMedicine #radonc

Learn more about how we’re helping bring tech and aviation together – watch the video now

A press release summarizes what I thought was the most important lung cancer abstract presented at #ASTRO25. It represents the updated REVISED STARS study results from MDACC. https://t.co/u6wWDW7lvR

If the faces are familiar, then you'll know that if we're in the same room together, something tectonic is happening. #FORESEE 🚀

Here's a slide from the presentation.

A press release summarizes what I thought was the most important lung cancer abstract presented at #ASTRO25. It represents the updated REVISED STARS study results from MDACC. https://t.co/u6wWDW7lvR

Your Pipedrive journey starts here! Track your sales pipeline with the easy and effective CRM for closing deals.

Say hello to Labubu RadOnc. You can find them in @AnnRaldow_MD's office!

Claudia Henschke shows data that benign-appearing subsolid lung nodules (cTis) that are concerning enough to treat are malignant >90% of the time. 🫁

https://t.co/DL50UAKjIt

New data from Claudia Henschke shows visceral pleural invasion by itself doesn’t increase the risk of relapse for SUBSOLID lung cancers.

$RGBP $RGBPP Regen presenting at Emerging Growth Conference on Thursday ... October 23, 2025 at 4:10 pm Eastern Time. This will be an update on HemaXellerate's Orphan Drug Application, Reg A fund raising for beginning Clinical Phase I and responding to questions. Regester at:

I’m filled with joy to see my mentor and friend land his 2nd NEJM article after a 20+ year journey defining how to prognosticate PSA relapse and guiding @AstellasUS to design a trial that worked and improved survival. Congrats Steve! @SFreedlandMD

Glad to see 95% of upfront resectable remaining resectable. This value resembles our institutional outcomes which relies on diligent preop assessments. From my perspective 95% getting to the OR should be the expected outcome, not 80% as shown in the global trials that were

Few people realize how much $$$ insurance companies pay specialist doctors to spend their time finding reasons to deny care provided by other specialists.

https://t.co/1Vh1ESvwZ8

This skin thing is INSANE to me. Valve is crashing the market for profit Normally I try to go with the flow & take changes on the chin. This is so big it may end CS as a tier 1 ESPORT. Valve with a generational miss. If you need a TLDR or want to know more watch this.

#ESMO25 NorthStar shines bright for EGFR+ metastatic lung cancer! 🌟 Adding local consolidative therapy (like radiation/surgery) to Osimertinib significantly improves PFS (25.4 mos vs 17.0 mos) @BalazsHalmosMD @StephenVLiu @FordePatrick @drpragya_shukla #Pranshumohindra

The long-awaited results of NORTHSTAR are finally reported at #ESMO25. @fifimcdrmh

@DrewMoghanaki @DoctorJSpicer @SBroderickMD